Open access in silico tools to predict the ADMET profiling of drug candidates

Supratik Kar, Jerzy Leszczynski

Research output: Contribution to journalReview articlepeer-review

137 Scopus citations

Abstract

Introduction: We are in an era of bioinformatics and cheminformatics where we can predict data in the fields of medicine, the environment, engineering and public health. Approaches with open access in silico tools have revolutionized disease management due to early prediction of the absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles of the chemically designed and eco-friendly next-generation drugs. Areas covered: This review meticulously encompasses the fundamental functions of open access in silico prediction tools (webservers and standalone software) and advocates their use in drug discovery research for the safety and reliability of any candidate-drug. This review also aims to help support new researchers in the field of drug design. Expert opinion: The choice of in silico tools is critically important for drug discovery and the accuracy of ADMET prediction. The accuracy largely depends on the types of dataset, the algorithm used, the quality of the model, the available endpoints for prediction, and user requirement. The key is to use multiple in silico tools for predictions and comparing the results, followed by the identification of the most probable prediction.

Original languageEnglish
Pages (from-to)1473-1487
Number of pages15
JournalExpert Opinion on Drug Discovery
Volume15
Issue number12
DOIs
StatePublished - Dec 2020

Keywords

  • ADMET
  • drug
  • in silico
  • open access
  • prediction

Fingerprint

Dive into the research topics of 'Open access in silico tools to predict the ADMET profiling of drug candidates'. Together they form a unique fingerprint.

Cite this